Antiviral Frontiers is a Kimer Med podcast
Antiviral Frontiers is a new podcast series by Kimer Med, in which we dive deep into the fascinating world of viruses. Each episode explores the latest discoveries and untold stories at the intersection of virology, biotech, and medicine. Join us as we talk all things viral and antiviral with a stimulating selection of guests from all corners of the globe.
Antiviral Frontiers is available on YouTube and Spotify. You can click on the icons below to select your preferred platform, or scroll down to explore episodes.
Podcast episodes
The first 5 episodes of Antiviral Frontiers are listed below. We hope to create more episodes as time allows.
S1E1 - The Viral Link to Alzheimer's Disease with Ruth Itzhaki
In this episode, Emeritus Professor Ruth Itzhaki discusses her extensive research on the potential link between viral infections, particularly herpes simplex virus (HSV1), and Alzheimer's disease.
S1E2 - Fighting Antibiotic Resistant Bacteria with Viral Phage Therapy
In this conversation, Rick Kiessig interviews William Colton, a microbiologist and entrepreneur, about his work in phage therapy and hydrogel technology. They discuss the mechanisms of phage therapy, the challenges of antibiotic resistance, and the innovative use of hydrogels for drug delivery.
S1E3 - Unlocking the Secrets of Bat Immunology with Matae Ahn
Rick Kiessig talks with Assistant Professor Matae Ahn, a researcher focused on bat immunology and longevity. Matae discusses his background, the unique immune responses of bats, and how their biology may inform human health.
S1E4 - Endogenous Retroviruses (ERVs): Fossil record of ancient viral pandemics
In this conversation recorded for the Antiviral Frontiers podcast, Kimer Med's Rick Kiessig and Professor John Coffin of Tufts University delve into the fascinating world of retroviruses, particularly focusing on HIV and endogenous retroviruses (ERVs).
S1E5 - Drug Discovery Insights with Dr. Derek Lowe
Dr. Derek Lowe, a seasoned drug discovery expert, shares insights into the complexities of drug development, from the initial discovery phase to clinical trials and the importance of intellectual property. He discusses the evolving role of AI in drug development, the challenges faced by biotech companies, and the significance of collaboration between academia and industry.
MORE MEDIA:
Learn more about viruses, antivirals and the need for our products.
Kimer Med is taking on the global health challenges of viral disease and future pandemic threats. We regularly publish articles on these subjects.